Medically reviewed on August 23, 2018.
Applies to the following strengths: 40 mg; 120 mg; 20 mg; 80 mg; 160 mg
Usual Adult Dose for:
Additional dosage information:
Usual Adult Dose for Angina Pectoris
Initial dose: 40 mg orally once a day; may be increased by 40 to 80 mg every 3 to 7 days until optimum response is obtained or pronounced heart rate reduction occurs
Maintenance dose: 40 to 80 mg orally once a day; up to 240 mg once a day may be required
Maximum dose: 240 mg/day
Usual Adult Dose for Hypertension
Initial dose: 40 mg orally once a day; may be increased in 40 to 80 mg increments until optimum blood pressure reduction is achieved
Maintenance dose: 40 to 80 mg orally once a day; up to 320 mg once a day may be required
Renal Dose Adjustments
CrCl greater than 50 mL/min/1.73 m2: Administer every 24 hours
CrCl 31 to 50 mL/min/1.73 m2: Administer every 24 to 36 hours
CrCl 10 to 30 mL/min/1.73 m2: Administer every 24 to 48 hours
CrCl less than 10 mL/min/1.73 m2: Administer every 40 to 60 hours
Liver Dose Adjustments
Data not available
US BOXED WARNING:
-DISCONTINUING THERAPY: Hypersensitivity to catecholamines has been observed in patients withdrawn from beta-blocker therapy; exacerbation of angina and, in some cases, myocardial infarction have occurred after abrupt discontinuation of such therapy. When discontinuing chronically administered nadolol, particularly in patients with ischemic heart disease, the dosage should be gradually reduced over a period of 1 to 2 weeks and the patient should be carefully monitored. If angina markedly worsens or acute coronary insufficiency develops, nadolol administration should be reinstituted promptly, at least temporarily, and other measures appropriate for the management of unstable angina should be taken. Patients should be warned against interruption or discontinuation of therapy without the physician's advice. Because coronary artery disease is common and may be unrecognized, it may be prudent not to discontinue nadolol therapy abruptly even in patients treated only for hypertension.
Safety and efficacy have not been established in patients younger than 18 years.
Consult WARNINGS section for additional precautions.
Data not available
Storage requirements: Protect from light.
Patient advice: Caution patients against interruption or cessation of therapy without a physician's advice.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about nadolol
- Nadolol Side Effects
- During Pregnancy or Breastfeeding
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 33 Reviews
- Drug class: non-cardioselective beta blockers
Other brands: Corgard